Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Urru SAM, Gallus S, Bosetti C, Moi T, Medda R, Sollai E, Murgia A, Sanges F, Pira G, Manca A, Palmas D, Floris M, Asunis AM, Atzori F, Carru C, D'Incalci M, Ghiani M, Marras V, Onnis D, Santona MC, Sarobba G, Valle E, Canu L, Cossu S, Bulfone A, Rocca PC, De Miglio MR, Orrù S. Urru SAM, et al. Among authors: orru s. BMC Cancer. 2018 Jan 8;18(1):56. doi: 10.1186/s12885-017-3969-y. BMC Cancer. 2018. PMID: 29310602 Free PMC article.
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population.
Palomba G, Loi A, Uras A, Fancello P, Piras G, Gabbas A, Cossu A, Budroni M, Contu A, Tanda F, Farris A, Orrù S, Floris C, Pisano M, Lovicu M, Santona MC, Landriscina G, Crisponi L, Palmieri G, Monne M. Palomba G, et al. Among authors: orru s. BMC Cancer. 2009 Jul 20;9:245. doi: 10.1186/1471-2407-9-245. BMC Cancer. 2009. PMID: 19619314 Free PMC article.
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
Cossu-Rocca P, Orrù S, Muroni MR, Sanges F, Sotgiu G, Ena S, Pira G, Murgia L, Manca A, Uras MG, Sarobba MG, Urru S, De Miglio MR. Cossu-Rocca P, et al. Among authors: orru s. PLoS One. 2015 Nov 5;10(11):e0141763. doi: 10.1371/journal.pone.0141763. eCollection 2015. PLoS One. 2015. PMID: 26540293 Free PMC article.
Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis.
Sanges F, Floris M, Cossu-Rocca P, Muroni MR, Pira G, Urru SAM, Barrocu R, Gallus S, Bosetti C, D'Incalci M, Manca A, Uras MG, Medda R, Sollai E, Murgia A, Palmas D, Atzori F, Zinellu A, Cambosu F, Moi T, Ghiani M, Marras V, Santona MC, Canu L, Valle E, Sarobba MG, Onnis D, Asunis A, Cossu S, Orrù S, De Miglio MR. Sanges F, et al. Among authors: orru s. BMC Cancer. 2020 Jun 2;20(1):491. doi: 10.1186/s12885-020-06998-9. BMC Cancer. 2020. PMID: 32487046 Free PMC article.
Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target.
Koni M, Castellano I, Venturelli E, Sarcinella A, Lopatina T, Grange C, Cedrino M, Femminò S, Cossu-Rocca P, Orrù S, D'Ascenzo F, Cotellessa I, Tampieri C, Debernardi C, Cugliari G, Matullo G, Camussi G, De Miglio MR, Brizzi MF. Koni M, et al. Among authors: orru s. Cancers (Basel). 2022 Aug 13;14(16):3918. doi: 10.3390/cancers14163918. Cancers (Basel). 2022. PMID: 36010912 Free PMC article.
Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype.
Angius A, Pira G, Cossu-Rocca P, Sotgiu G, Saderi L, Muroni MR, Virdis P, Piras D, Vincenzo R, Carru C, Coradduzza D, Uras MG, Cottu P, Fancellu A, Orrù S, Uva P, De Miglio MR. Angius A, et al. Among authors: orru s. J Cancer Res Clin Oncol. 2023 Jul;149(7):3951-3963. doi: 10.1007/s00432-022-04301-w. Epub 2022 Aug 28. J Cancer Res Clin Oncol. 2023. PMID: 36030436 Free PMC article.
193 results